Vulnerability Description
IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Ibm | Aspera Faspex | <= 4.4.1 |
| Linux | Linux Kernel | - |
| Microsoft | Windows | - |
Related Weaknesses (CWE)
References
- https://exchange.xforce.ibmcloud.com/vulnerabilities/244117VDB EntryVendor Advisory
- https://www.ibm.com/support/pages/node/6952319PatchVendor Advisory
- https://exchange.xforce.ibmcloud.com/vulnerabilities/244117VDB EntryVendor Advisory
- https://www.ibm.com/support/pages/node/6952319PatchVendor Advisory
FAQ
What is CVE-2023-22868?
CVE-2023-22868 is a vulnerability with a CVSS score of 5.4 (MEDIUM). IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially lea...
How severe is CVE-2023-22868?
CVE-2023-22868 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2023-22868?
Check the references section above for vendor advisories and patch information. Affected products include: Ibm Aspera Faspex, Linux Linux Kernel, Microsoft Windows.